Study of combination regimen for previously untreated older patients with acute myeloid leukemia (AML)
- Conditions
- ntreated patients aged 60> years with Acute Myeloid LeukemiaMedDRA version: 15.0Level: PTClassification code 10000880Term: Acute myeloid leukaemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Registration Number
- EUCTR2012-000334-19-IT
- Lead Sponsor
- AZIENDA OSPEDALIERA OSPEDALE S. SALVATORE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Male and female patients aged > 60 years Signed informed consent Morphologically confirmed diagnosis of acute myeloid leukemia by bone marrow aspiration within the past 14 days
Are the trial subjects under 18? no
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 40
Exclusion Criteria
HIV infection HCV positivity Active second malignancy Diagnosis of relapsed acute promyelocitic leukemia
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method